Wai Yuen Tong Medicine Holdings Limited commences an Equity Buyback Plan for 40,000,000 shares, representing 10% of its issued share capital, under the authorization granted on August 18, 2022.

Hing Ming Holdings Limited commences share repurchases on September 20,2022 under the program mandated by the shareholders in the Annual General Meeting held on August 18, 2022. As per the mandate, the company is authorized to repurchase up to 40,000,000 shares, representing 10% of the issued share capital. The repurchases will result in an increase in the earnings per share.

Repurchases made pursuant to the New Repurchase Mandate would be funded from the Company's available cash flow or working capital facilities legally available for the purpose in accordance with the Company's memorandum of association, the Bye-Laws, the applicable laws and regulations of Bermuda and other applicable laws. The authority shall expire at the earliest of the next Annual General Meeting, the date on which the next Annual General Meeting is required to be held or the date on which the authority is varied or revoked in a General Meeting. As at August 18, 2022, the company has 400,000,000 shares in issue.